FDA Expands Warning to Consumers About Tained Weight Loss Pills.

FDA Expands Warning to Consumers About Tained Weight Loss Pills.

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2009-03-01
Series:	Ожирение и метаболизм
Online Access:	https://www.omet-endojournals.ru/jour/article/view/5115

Similar Items

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing
by: Seon-Hee Yim, et al.
Published: (2014-12-01)

Hippolyte Taine, Voyage en Italie
by: Thierry Poyet

"Endless Forms" of Evolution? Heuristics in Darwin and Taine.
by: Andrew Court
Published: (2006-08-01)

"Endless Forms" of Evolution? Heuristics in Darwin and Taine.
by: Andrew Court
Published: (2006-08-01)

Flaubert et Taine devant l’image
by: Bernard Vouilloux
Published: (2014-10-01)

Insights from FDA Warning Letters
Published: (2010-01-01)

Network analysis of Beowulf, the Iliad and the Táin Bó Cúailnge
by: Mac Carron, P, et al.
Published: (2014)

Development of a mechatronics weight loss pill
by: Andy Prima Kencana
Published: (2010)

Design and development of mechatronics weight loss pill
by: Chua, Xing Rong.
Published: (2013)

Systemic ketoconazole continues to be prescribed despite an FDA warning
by: Suraj Muddasani, et al.
Published: (2022-04-01)

Structural Synthesis of Uncertain Joints in the Drawings of Tain Gong Kai Wu
by: Hong-Sen YAN, et al.
Published: (2010-08-01)

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters
by: Hyosun Kim
Published: (2015-12-01)

About Pill Protect®
by: Joelle Michaud, et al.
Published: (2016-12-01)

Public Perceptions of Breast Implant Complications and the FDA Boxed Warning on Implants
by: Colby J. Hyland, AB, et al.
Published: (2022-11-01)

Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
by: John B. Hagan, MD, et al.
Published: (2022-02-01)

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
by: Acemoglu, Daron, et al.
Published: (2015)

Effect of Enzymatic Hydrolysis on the Weight Loss and Pilling of Cotton and Cotton/Polyester Fabrics
by: A. Khodami, et al.
Published: (1998-03-01)

Assessments of ecological health using soil algae diversity in Jargalant-Tain pass, Bogdkhan mountain
by: Bukhchuluun Tsegmid
Published: (2021-09-01)

Barriers and opportunities in effective management of forest landscape restoration: Tain II degraded forest restoration, Ghana
by: Samuel Kumi, et al.
Published: (2024-03-01)

A Genealogy of XIXth Century French Criticism—Typology, Physiology and Genealogy in Sainte-Beuve, Taine and Nietzsche
by: Arnaud Sorosina
Published: (2021-08-01)

Impact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatients.
by: Chia-Chen Hsu, et al.
Published: (2014-01-01)

Correction/clarification about FDA review documents.
Published: (2005-12-01)

The Conundrum of Online Prescription Drug Promotion Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Isaac Wanasika
Published: (2016-06-01)

The Tip of the Iceberg of Misleading Online Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Barbara Mintzes
Published: (2016-05-01)

An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims
by: Chatterjee S, et al.
Published: (2012-12-01)

Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
by: Yanglong Li, et al.
Published: (2021-11-01)

Still the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Brent L. Rollins
Published: (2016-04-01)

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
by: Michele Fornaro, et al.
Published: (2019-05-01)

Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Tim K. Mackey
Published: (2016-04-01)

Pills, Pills, and More Pills: A Pill Box Exercise to Teach Barriers to Medication Adherence and Solutions
by: Kathryn Denson, et al.
Published: (2015-11-01)

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force
by: Jacqueline A. French, et al.
Published: (2021-03-01)

Future Challenges and Opportunities in Online Prescription Drug Promotion Research; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Brian G. Southwell, et al.
Published: (2016-03-01)

The development of an assesment framework for vocational education taining programmes in the noss based training system (NBTS) and the national dual training system (NDTS)
by: Muhammad Zain, Ruminah
Published: (2016)

FDA-MIMO Radar Robust Beamforming Based on Matrix Weighting Method
by: Changlin Zhou, et al.
Published: (2022-01-01)

Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries
by: Hyosun Kim
Published: (2016-10-01)

Could the vaginal wall sling still have a role after the FDA’s warning? Functional outcomes at 20 years
by: Ester Illiano, et al.
Published: (2022-03-01)

Capsaicin for Weight Control: “Exercise in a Pill” (or Just Another Fad)?
by: Arpad Szallasi
Published: (2022-07-01)

Littérature et transmission patrimoniale. La question du genius loci siennois chez Hippolyte Taine, André Suarès et Dominique Fernandez
by: Ema Galifi
Published: (2022-09-01)

Mathematical modelling and control of African animal trypanosomosis with interacting populations in West Africa-Could biting flies be important in main taining the disease endemicity?
by: Paul Olalekan Odeniran, et al.
Published: (2020-01-01)

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
by: Afsaneh Shirani, et al.
Published: (2024-04-01)